New scanner could slash repeat breast cancer surgeries

NCT ID NCT06958991

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a special scanner that helps surgeons see if any cancer cells are left behind during breast-conserving surgery. The goal is to remove all cancer in one go and avoid a second operation. About 100 women with invasive or in-situ breast cancer will take part. The scanner is already approved for use, and the study focuses on how well it works in routine practice.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Confocal histolog scanner (device)
What this could lead to
If successful, this scanner could help surgeons remove all cancer in one operation, reducing the need for additional surgeries.
What could go wrong
This is a small, early-stage study with only 100 participants. The device is already approved, but it may not improve outcomes significantly or work for all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER INVASIVE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • HFR

    RECRUITING

    Villars-sûr-glâne, Canton of Fribourg, 1752, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.